Ladivella

Dienogest and Estradiol Valerate, the active ingredients in Ladivella, are a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age by inhibiting ovulation and creating an unfavorable environment for fertilisation.

GNH USA supplies Ladivella as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ladivella, a combined oral contraceptive, is indicated for hormonal contraception in women.

- Prevention of pregnancy: provides reliable contraceptive protection for women of childbearing potential. - Treatment of moderate acne: helps reduce acne lesions by regulating androgenic activity. - Management of endometriosis symptoms: alleviates pain associated with endometriosis through hormonal suppression.

Common side effects are generally mild and transient.

Common Side Effects: - Nausea: occasional stomach upset. - Breast tenderness: mild discomfort in the breasts. - Headache: mild to moderate intensity. - Breakthrough bleeding: spotting between periods. - Weight fluctuation: modest changes in body weight. - Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins. - Arterial thrombosis: clot formation in arteries. - Hypertension: elevated blood pressure. - Liver tumours: benign hepatic adenomas. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden changes in vision.

Before prescribing Ladivella, clinicians should evaluate individual risk factors and counsel patients on safe use. - Thrombotic risk assessment: avoid in women with history of clotting disorders. - Blood pressure monitoring: contraindicated in uncontrolled hypertension. - Smoking status: discourage smoking in women over 35 years. - Liver function review: caution in hepatic impairment. - Drug history check: assess for interacting medications. - Store at ambient temperature: keep in original packaging, protect from moisture.

Ladivella may have clinically relevant interactions that require attention.

Major Interactions (Avoid): - Strong enzyme inducers (e.g., rifampin, carbamazepine): may reduce contraceptive efficacy. - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Certain antiretrovirals (e.g., protease inhibitors): may alter hormone levels.

Moderate Interactions (Monitor Closely): - Antiepileptic drugs (e.g., phenytoin): may decrease contraceptive effectiveness. - Antibiotics such as griseofulvin: potential reduction in hormone concentrations. - Herbal supplements (e.g., St. John’s wort): may lower plasma levels of active ingredients.